Home Nvelop Therapeutics

Nvelop Therapeutics

In operation
Seed Round Financing
Gene Editing Technology Researcher
Basic
Enterprise Profile

Basic Information

Nvelop Therapeutics is a gene editing technology service provider dedicated to utilizing novel delivery technologies for gene editing, with a focus on unmet needs of serious diseases. It has developed engineered virus-like particles (eVLP). Its mission is to leverage innovative gene editing delivery technologies to develop transformative gene therapies, with an emphasis on diseases with significant unmet medical needs.
Nvelop Therapeutics
Cambridge,Massachusetts,United States of America
15~50 people
January 01, 2022
careers@NvelopTx.com

Enterprise Profile

Industrial Sector
New Drug Development Gene Therapy Production of Genetically Engineered Drugs
Technology
Gene Editing
Concept
Therapeutic Products
Application Scenarios
Innovative Drugs Cell and Gene Therapy